ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $352.85 million. The enterprise value is $411.52 million.
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 100.53 million shares outstanding. The number of shares has increased by 1.19% in one year.
| Current Share Class | 100.53M |
| Shares Outstanding | 100.53M |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 6.08% |
| Owned by Institutions (%) | 54.48% |
| Float | 49.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| Forward PS | 2.62 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.25
| Current Ratio | 3.25 |
| Quick Ratio | 2.95 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.70 |
Financial Efficiency
Return on equity (ROE) is -294.57% and return on invested capital (ROIC) is -173.90%.
| Return on Equity (ROE) | -294.57% |
| Return on Assets (ROA) | -39.49% |
| Return on Invested Capital (ROIC) | -173.90% |
| Return on Capital Employed (ROCE) | -105.72% |
| Weighted Average Cost of Capital (WACC) | 8.29% |
| Revenue Per Employee | $592,893 |
| Profits Per Employee | -$970,233 |
| Employee Count | 206 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 6.78 |
Taxes
| Income Tax | -80,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.27% in the last 52 weeks. The beta is 1.16, so SPRY's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -56.27% |
| 50-Day Moving Average | 4.04 |
| 200-Day Moving Average | 7.00 |
| Relative Strength Index (RSI) | 47.26 |
| Average Volume (20 Days) | 2,378,838 |
Short Selling Information
The latest short interest is 18.99 million, so 18.89% of the outstanding shares have been sold short.
| Short Interest | 18.99M |
| Short Previous Month | 19.82M |
| Short % of Shares Out | 18.89% |
| Short % of Float | 38.67% |
| Short Ratio (days to cover) | 11.50 |
Income Statement
In the last 12 months, SPRY had revenue of $122.14 million and -$199.87 million in losses. Loss per share was -$2.01.
| Revenue | 122.14M |
| Gross Profit | 56.01M |
| Operating Income | -197.25M |
| Pretax Income | -199.95M |
| Net Income | -199.87M |
| EBITDA | -195.60M |
| EBIT | -197.25M |
| Loss Per Share | -$2.01 |
Full Income Statement Balance Sheet
The company has $138.35 million in cash and $197.02 million in debt, with a net cash position of -$58.66 million or -$0.58 per share.
| Cash & Cash Equivalents | 138.35M |
| Total Debt | 197.02M |
| Net Cash | -58.66M |
| Net Cash Per Share | -$0.58 |
| Equity (Book Value) | -11.96M |
| Book Value Per Share | -0.12 |
| Working Capital | 146.13M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -183.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.65M |
| Net Borrowing | 24.24M |
| Free Cash Flow | -183.07M |
| FCF Per Share | -$1.82 |
Full Cash Flow Statement Margins
Gross margin is 45.86%, with operating and profit margins of -161.50% and -163.64%.
| Gross Margin | 45.86% |
| Operating Margin | -161.50% |
| Pretax Margin | -163.71% |
| Profit Margin | -163.64% |
| EBITDA Margin | -160.15% |
| EBIT Margin | -161.50% |
| FCF Margin | n/a |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.19% |
| Shareholder Yield | -1.19% |
| Earnings Yield | -57.39% |
| FCF Yield | -50.73% |
Analyst Forecast
The average price target for SPRY is $17.00, which is 384.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 384.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 43.16% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of -2.03 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.03 |
| Piotroski F-Score | 1 |